Director Business Development & Investor RelationsDr. Holger Neecke Ph.D. serves as Director of Business Development Investor Relations at Molecular Medicine S.p.A. He joined the Company in October 2001. Before that he worked at Biopolo Scrl where he developed and evaluated business plans for startup companies. At the Company he has acquired experience in biotech business development particularly by structuring negotiating and finalizing license agreements with pharmacy and biotech companies and institutions in Europe Japan and the United States. He gained a degree in Molecular Biology from Universitaet Basel a Masters of Business Administration from Universita Commerciale Luigi Bocconi and a Doctorate in Philosophy in Genetics from Universita degli Studi di Milano.